Procter & Gamble Health Ltd.
Snapshot View

4392.50 +16.50 ▲0.4%

16 August 2022, 04:01:00 PM
Volume: 722

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.pghealthindia.com
Market Cap 7,273.19 Cr.
Enterprise Value(EV) 7,046.32 Cr. 2021-12
Financial Indicators
Earnings per share (EPS) 111.61 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 39.26 Trailing Twelve Months Ending 2022-03
Industry PE 32.02 Trailing Twelve Months Ending 2022-03
Book Value / Share 384.53 Trailing Twelve Months Ending 2022-03
Price to Book Value 11.39 Calculated using Price: 4,381.60
Dividend Yield 2.97 Period Ending 2021-06
No. of Shares Subscribed 1.66 Cr. 16,599,382 Shares
FaceValue 10
Company Profile
Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country. The company is one of India's largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.38%
1 Week
-0.35%
1 Month
+4.41%
3 Month
+1.13%
6 Month
-8.16%
1 Year
-19.71%
2 Year
-6.22%
5 Year
+299.34%
10 Year
+608.35%
9 years 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2020-06 2021-06
Return on Equity (%) 17.54 11.10 8.02 9.35 12.61 13.44 73.79 20.79 22.04
Return on Capital Employed (%) 26.14 17.53 12.36 14.54 18.35 21.79 80.76 29.01 29.08
Return on Assets (%) 8.16 6.71 4.67 3.92 5.48 6.52 40.93 10.82 8.65

Balance Sheet View Details >>

Particulars 10 years 2012-12 Rs. Cr. 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2020-06 Rs. Cr. 2021-06 Rs. Cr. 2021-12* Rs. Cr.
Shh. Funds 484 523 554 592 664 733 1,540 906 704 587
Non Curr. Liab. 338 13 390 395 399 431 495 667 723 24
Curr. Liab. 195 112 260 539 301 352 548 539 551 216
Minority Int.
Equity & Liab. 1,016 648 1,204 1,525 1,363 1,516 2,583 2,112 1,978 828
Non Curr. Assets 460 171 581 579 613 637 693 847 939 245
Curr. Assets 557 478 623 946 750 879 1,889 1,265 1,039 583
Misc. Exp. not W/O
Total Assets 1,016 648 1,204 1,525 1,363 1,516 2,583 2,112 1,978 828

Profit Loss View Details >>

Particulars 10 years 2012-12 Rs. Cr. 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2020-06 Rs. Cr. 2021-06 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 687 798 867 940 993 698 1,288 1,356 1,009 1,104
Other Income 20 21 20 23 24 84 722 70 18 13
Total Income 707 819 888 963 1,017 782 2,010 1,426 1,027 1,116
Total Expenditure -582 -721 -809 -856 -877 -628 -1,078 -1,042 -763 -847
PBIDT 126 98 79 107 140 154 932 384 264 270
Interest -1 -1
Depreciation -9 -10 -13 -23 -25 -19 -21 -29 -30 -27
Taxation -38 -32 -23 -30 -36 -58 -79 -101 -56 -57
Exceptional Items 17 7
PAT 78 56 43 54 79 94 839 254 177 185
Adjusted EPS 47 34 26 32 48 57 505 153 107 112

Cash Flow View Details >>

Particulars 10 years 2011-12 Rs. Cr. 2012-12 Rs. Cr. 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2020-06 Rs. Cr. 2021-06 Rs. Cr.
Cash Fr. Operatn. 19 54 0 5 83 107 54 -130 235 247
Cash Fr. Inv. -9 -82 7 11 -68 -75 -48 1,270 165 -32
Cash Fr. Finan. 0 -5 -17 -12 -15 -22 -30 -883 -387
Net Change 10 -28 3 -1 4 17 -16 1,109 -483 -172
Cash & Cash Eqvt 31 4 7 5 9 26 10 1,119 636 464

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 51.82 51.82 51.82 51.82 51.82 51.82 51.82 51.82 51.82
Public 48.18 48.18 48.18 48.18 48.18 48.18 48.18 48.18 48.18
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 12 Aug 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we hereby inform you regarding issue of duplicate share certificate(s) to the shareholder(s) of the Company on August 11 2022.We request you to take the same on record and acknowledge the receipt.
Fri, 05 Aug 2022
Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On August 29 2022
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2022 inter alia to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday August 29 2022 inter alia to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30 2022 and to consider recommendation of dividend (if any).
Wed, 03 Aug 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our Registrars and Share Transfer Agents (RTA) KFin Technologies Limited on August 03 2022 regarding the loss /misplacement of the share certificate(s).We request you to take the same on record and acknowledge receipt.

Technical Scans View Details >>

Fri, 12 Aug 2022
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Increase 5 Years High Increase 5 Years
Closing Near 20 SMA Closing Near 20 SMA
Close Crossing 20 SMA From Below Close Crossing 20 SMA From Below
Close Crossing 20 EMA From Below Close Crossing 20 EMA From Below

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 914.60 +0.1%
Divi's Laboratories Ltd. 98,918.90 3,732.00 +0.2%
Cipla Ltd. 82,906.37 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. 51,917.53 1,569.90 +2.0%
Piramal Enterprises Ltd. 45,855.65 1,926.70 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 33.32 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,926.70 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 3.86 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,926.70 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,926.70 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,926.70 +0.3%

FAQ's On Procter & Gamble Health Ltd.

Can I Buy Procter&Gamble Healt Shares now?

What is the Share Price of Procter&Gamble Healt?

What is the Relative Strength Index (RSI) Value of Procter&Gamble Healt?

What is the Market Capital (MCAP) of Procter&Gamble Healt?

What are the key metrics to analyse Procter&Gamble Healt?

What is the Price Performance of Procter&Gamble Healt?